Loss of detoxification in inflammatory bowel disease: Dysregulation of pregnane X receptor target genes

Gastroenterology

Volumn 127, Issue 1, 2004, Pages 26-40

  Langmann, Thomas ^a   Moehle, Christoph ^a   Mauerer, Richard ^a   Scharl, Michael ^a   Liebisch, Gerhard ^a   Zahn, Alexandra ^b   Stremmel, Wolfgang ^b   Schmitz, Gerd ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

complementary RNA; cRNA; CYP; cytochrome P450; glutathione S transferase; GST; IL; interleukin; pregnane X receptor; PXR; reverse transcription polymerase chain reaction; ribosomal RNA; rRNA; RT PCR; sulfotransferase; SULT; TNF; tumor necrosis factor

Indexed keywords

PREGNANE X RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; CHILD; COLON; CONTROLLED STUDY; CROHN DISEASE; DETOXIFICATION; DOWN REGULATION; ENTERITIS; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE TARGETING; HUMAN; ILEUM; INTESTINE EPITHELIUM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS;

EID: 3242735503     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.04.019     Document Type: Article

References (68)

1. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:2001;599-603
2. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., Cho J.H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 411:2001;603-606
3. Mizoguchi A., Mizoguchi E., Bhan A.K. Immune networks in animal models of inflammatory bowel disease. Inflamm Bowel Dis. 9:2003;246-259
4. Podolsky D.K. Inflammatory bowel disease. N Engl J Med. 347:2002;417-429
5. Andoh A., Saotome T., Sato H., Tsujikawa T., Araki Y., Fujiyama Y., Bamba T. Epithelial expression of caveolin-2, but not caveolin-1, is enhanced in the inflamed mucosa of patients with ulcerative colitis. Inflamm Bowel Dis. 7:2001;210-214
6. Yoshikai Y. The interaction of intestinal epithelial cells and intraepithelial lymphocytes in host defense. Immunol Res. 20:1999;219-235
7. Groh V., Steinle A., Bauer S., Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science. 279:1998;1737-1740
8. Podolsky D.K. Mucosal immunity and inflammation. V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense. Am J Physiol. 277:1999;G495-G499
9. Rath H.C., Schultz M., Freitag R., Dieleman L.A., Li F., Linde H.J., Scholmerich J., Sartor R.B. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun. 69:2001;2277-2285
10. Hermiston M.L., Gordon J.I. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science. 270:1995;1203-1207
11. Gibson P., Rosella O., Nov R., Young G. Colonic epithelium is diffusely abnormal in ulcerative colitis and colorectal cancer. Gut. 36:1995;857-863
12. Jankowski J.A., Bedford F.K., Boulton R.A., Cruickshank N., Hall C., Elder J., Allan R., Forbes A., Kim Y.S., Wright N.A., Sanders D.S. Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis. Lab Invest. 78:1998;1155-1167
13. Kinugasa T., Sakaguchi T., Gu X., Reinecker H.C. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology. 118:2000;1001-1011
14. Schmitz H., Barmeyer C., Fromm M., Runkel N., Foss H.D., Bentzel C.J., Riecken E.O., Schulzke J.D. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology. 116:1999;301-309
15. Puspok A., Oberhuber G., Wyatt J., Maier-Dobersberger T., Hammer J., Pfeffel F., Wrba F., Potzi R., Vogelsang H. Gastroduodenal permeability in Crohn's disease. Eur J Clin Invest. 28:1998;67-71
16. Gassler N., Rohr C., Schneider A., Kartenbeck J., Bach A., Obermuller N., Otto H.F., Autschbach F. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol. 281:2001;G216-G228
17. Roediger W.E., Babidge W. Human colonocyte detoxification. Gut. 41:1997;731-734
18. Ding X., Kaminsky L.S. Human extrahepatic cytochromes P450 function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol. 43:2003;149-173
19. Fonti R., Latella G., Caprilli R., Frieri G., Marcheggiano A., Sambuy Y. Carbonic anhydrase I reduction in colonic mucosa of patients with active ulcerative colitis. Dig Dis Sci. 43:1998;2086-2092
20. Schwer H., Langmann T., Daig R., Becker A., Aslanidis C., Schmitz G. Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver. Biochem Biophys Res Commun. 233:1997;117-120
21. Chen G., Zhang D., Jing N., Yin S., Falany C.N., Radominska-Pandya A. Human gastrointestinal sulfotransferases identification and distribution. Toxicol Appl Pharmacol. 187:2003;186-197
22. Back D.J., Rogers S.M. Review first-pass metabolism by the gastrointestinal mucosa. Aliment Pharmacol Ther. 1:1987;339-357
23. Pacifici G.M., Franchi M., Bencini C., Repetti F., Di Lascio N., Muraro G.B. Tissue distribution of drug-metabolizing enzymes in humans. Xenobiotica. 18:1988;849-856
24. Toyota M., Itoh F., Kikuchi T., Satoh A., Obata T., Suzuki H., Ishii S., Endo T., Tokino T., Imai K. DNA methylation changes in gastrointestinal disease. J Gastroenterol. 37:(Suppl 14):2002;97-101
25. McCarver D.G., Hines R.N. The ontogeny of human drug-metabolizing enzymes phase II conjugation enzymes and regulatory mechanisms. J Pharmacol Exp Ther. 300:2002;361-366
26. Suzuki H., Sugiyama Y. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur J Pharm Sci. 12:2000;3-12
27. Martensson J., Jain A., Meister A. Glutathione is required for intestinal function. Proc Natl Acad Sci U S A. 87:1990;1715-1719
28. Loguercio C., D'Argenio G., Delle C.M., Cosenza V., Della V.N., Mazzacca G., Del Vecchio B.C. Glutathione supplementation improves oxidative damage in experimental colitis. Dig Liver Dis. 35:2003;635-641
29. Esworthy R.S., Aranda R., Martin M.G., Doroshow J.H., Binder S.W., Chu F.F. Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am J Physiol. 281:2001;G848-G855
30. Esworthy R.S., Binder S.W., Doroshow J.H., Chu F.F. Microflora trigger colitis in mice deficient in selenium-dependent glutathione peroxidase and induce Gpx2 gene expression. Biol Chem. 384:2003;597-607
31. Sido B., Hack V., Hochlehnert A., Lipps H., Herfarth C., Droge W. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut. 42:1998;485-492
32. Ho G.T., Moodie F.M., Satsangi J. Multidrug resistance 1 gene (P-glycoprotein 170) an important determinant in gastrointestinal disease? Gut. 52:2003;759-766
33. Langmann T., Mauerer R., Zahn A., Moehle C., Probst M., Stremmel W., Schmitz G. Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clin Chem. 49:2003;230-238
34. Panwala C.M., Jones J.C., Viney J.L. A novel model of inflammatory bowel disease mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol. 161:1998;5733-5744
35. Maggio-Price L., Shows D., Waggie K., Burich A., Zeng W., Escobar S., Morrissey P., Viney J.L. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Am J Pathol. 160:2002;739-751
36. Schwab M., Schaeffeler E., Marx C., Fromm M.F., Kaskas B., Metzler J., Stange E., Herfarth H., Schoelmerich J., Gregor M., Walker S., Cascorbi I., Roots I., Brinkmann U., Zanger U.M., Eichelbaum M. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology. 124:2003;26-33
37. Brant S.R., Panhuysen C.I., Nicolae D., Reddy D.M., Bonen D.K., Karaliukas R., Zhang L., Swanson E., Datta L.W., Moran T., Ravenhill G., Duerr R.H., Achkar J.P., Karban A.S., Cho J.H. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet. 73:2003;1282-1292
38. Fronhoffs S., Totzke G., Stier S., Wernert N., Rothe M., Bruning T., Koch B., Sachinidis A., Vetter H., Ko Y. A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction. Mol Cell Probes. 16:2002;99-110
39. Suzuki Y., Yamashita R., Nakai K., Sugano S. DBTSS DataBase of human Transcriptional Start Sites and full-length cDNAs. Nucleic Acids Res. 30:2002;328-331
40. Podvinec M., Kaufmann M.R., Handschin C., Meyer U.A. NUBIScan, an in silico approach for prediction of nuclear receptor response elements. Mol Endocrinol. 16:2002;1269-1279
41. Berge K.E., Tian H., Graf G.A., Yu L., Grishin N.V., Schultz J., Kwiterovich P., Shan B., Barnes R., Hobbs H.H. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 290:2000;1771-1775
42. Lee M.H., Lu K., Hazard S., Yu H., Shulenin S., Hidaka H., Kojima H., Allikmets R., Sakuma N., Pegoraro R., Srivastava A.K., Salen G., Dean M., Patel S.B. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet. 27:2001;79-83
43. Mizoguchi E., Xavier R.J., Reinecker H.C., Uchino H., Bhan A.K., Podolsky D.K., Mizoguchi A. Colonic epithelial functional phenotype varies with type and phase of experimental colitis. Gastroenterology. 125:2003;148-161
44. Maglich J.M., Stoltz C.M., Goodwin B., Hawkins-Brown D., Moore J.T., Kliewer S.A. Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol. 62:2002;638-646
45. Waxman D.J. P450 gene induction by structurally diverse xenochemicals central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys. 369:1999;11-23
46. Rosenfeld J.M., Vargas R. Jr, Xie W., Evans R.M. Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol Endocrinol. 17:2003;1268-1282
47. Hisamatsu T., Suzuki M., Reinecker H.C., Nadeau W.J., McCormick B.A., Podolsky D.K. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology. 124:2003;993-1000
48. Rosenstiel P., Fantini M., Brautigam K., Kuhbacher T., Waetzig G.H., Seegert D., Schreiber S. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology. 124:2003;1001-1009
49. Pascussi J.M., Gerbal-Chaloin S., Drocourt L., Maurel P., Vilarem M.J. The expression of CYP2B6, CYP2C9 and CYP3A4 genes a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta. 1619:2003;243-253
50. Heller R.A., Schena M., Chai A., Shalon D., Bedilion T., Gilmore J., Woolley D.E., Davis R.W. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci U S A. 94:1997;2150-2155
51. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 8:2002;500-508
52. Dieckgraefe B.K., Stenson W.F., Korzenik J.R., Swanson P.E., Harrington C.A. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics. 4:2000;1-11
53. Lawrance I.C., Fiocchi C., Chakravarti S. Ulcerative colitis and Crohn's disease distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet. 10:2001;445-456
54. Kendziorski C.M., Zhang Y., Lan H., Attie A.D. The efficiency of pooling mRNA in microarray experiments. Biostatistics. 4:2003;465-477
55. Mills J.C., Roth K.A., Cagan R.L., Gordon J.I. DNA microarrays and beyond completing the journey from tissue to cell. Nat Cell Biol. 3:2001;E175-E178
56. Coles B.F., Chen G., Kadlubar F.F., Radominska-Pandya A. Interindividual variation and organ-specific patterns of glutathione S-transferase alpha, mu, and pi expression in gastrointestinal tract mucosa of normal individuals. Arch Biochem Biophys. 403:2002;270-276
57. Duncan H., Swan C., Green J., Jones P., Brannigan K., Alldersea J., Fryer A.A., Strange R.C. Susceptibility to ulcerative colitis and Crohn's disease interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes. Clin Chim Acta. 240:1995;53-61
58. de Jong D.J., van der Logt E.M., van Schaik A., Roelofs H.M., Peters W.H., Naber T.H. Genetic polymorphisms in biotransformation enzymes in Crohn's disease association with microsomal epoxide hydrolase. Gut. 52:2003;547-551
59. Clapper M.L., Adrian R.H., Pfeiffer G.R., Kido K., Everley L., Cooper H.S., Murthy S. Depletion of colonic detoxication enzyme activity in mice with dextran sulphate sodium-induced colitis. Aliment Pharmacol Ther. 13:1999;389-396
60. Raouf A.H., Tsai H.H., Parker N., Hoffman J., Walker R.J., Rhodes J.M. Sulphation of colonic and rectal mucin in inflammatory bowel disease reduced sulphation of rectal mucus in ulcerative colitis. Clin Sci (Lond). 83:1992;623-626
61. Sabolovic N., Magdalou J., Netter P., Abid A. Nonsteroidal anti-inflammatory drugs and phenols glucuronidation in Caco-2 cells identification of the UDP-glucuronosyltransferases UGT1A6, 1A3 and 2B7. Life Sci. 67:2000;185-196
62. van Heel D.A., Satsangi J., Carey A.H., Jewell D.P. Inflammatory bowel disease progress toward a gene. Can J Gastroenterol. 14:2000;207-218
63. Farrell R.J., Murphy A., Long A., Donnelly S., Cherikuri A., O'Toole D., Mahmud N., Keeling P.W., Weir D.G., Kelleher D. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology. 118:2000;279-288
64. Iizasa H., Genda N., Kitano T., Tomita M., Nishihara K., Hayashi M., Nakamura K., Kobayashi S., Nakashima E. Altered expression and function of P-glycoprotein in dextran sodium sulfate-induced colitis in mice. J Pharm Sci. 92:2003;569-576
65. Kozoni V., Tsioulias G., Shiff S., Rigas B. The effect of lithocholic acid on proliferation and apoptosis during the early stages of colon carcinogenesis differential effect on apoptosis in the presence of a colon carcinogen. Carcinogenesis. 21:2000;999-1005
66. Zhang J., Kuehl P., Green E.D., Touchman J.W., Watkins P.B., Daly A., Hall S.D., Maurel P., Relling M., Brimer C., Yasuda K., Wrighton S.A., Hancock M., Kim R.B., Strom S., Thummel K., Russell C.G., Hudson J.R. Jr, Schuetz E.G., Boguski M.S. The human pregnane X receptor genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics. 11:2001;555-572
67. Kamiya A., Inoue Y., Gonzalez F.J. Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development. Hepatology. 37:2003;1375-1384
68. Uno Y., Sakamoto Y., Yoshida K., Hasegawa T., Hasegawa Y., Koshino T., Inoue I. Characterization of six base pair deletion in the putative HNF1-binding site of human PXR promoter. J Hum Genet. 48:2003;594-597